In this mouse study, an adenine base editor shows potential as a durable therapy for glycogen storage disease type-Ia, correcting both the life-threatening lack of blood glucose control and metabolic abnormalities of this orphan disease.
- Irina Arnaoutova
- Yvonne Aratyn-Schaus
- Janice Y. Chou
